Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy
about
Proteasome Activators, PA28α and PA28β, Govern Development of Microvascular Injury in Diabetic Nephropathy and RetinopathyOsteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.Pemt deficiency ameliorates endoplasmic reticulum stress in diabetic nephropathy.Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.Lipid biology of the podocyte--new perspectives offer new opportunities.An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF RatsEmerging role of liver X receptors in cardiac pathophysiology and heart failure.Soluble (pro)renin receptor via β-catenin enhances urine concentration capability as a target of liver X receptor.Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction.Nuclear hormone receptor expression in mouse kidney and renal cell lines.Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.Targeting liver X receptors in inflammation.Chinese medicines in the treatment of experimental diabetic nephropathy.Urinary Osteopontin Predicts Incident Chronic Kidney Disease, while Plasma Osteopontin Predicts Cardiovascular Death in Elderly Men.The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic NephropathyCD36 in chronic kidney disease: novel insights and therapeutic opportunities.Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization.Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.Saturated fatty acids bound to albumin enhance osteopontin expression and cleavage in renal proximal tubular cells.The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects.Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice.
P2860
Q28392941-5F582FA2-2EC2-4CF8-9FBC-06158C165EA0Q33766277-74DB9F9D-E8E6-4EDF-B3F7-9A3324BB5066Q35130934-97FD7BDD-A487-464D-AC35-6E428BAB3F3CQ35194026-BA102B86-B626-455F-A928-8A5D6038B07DQ35285568-FD4EBB7E-4F4B-4C5F-9E06-610D9E8668DFQ35852316-6962E652-A0C7-4E80-8E65-06A1A9AE81CEQ36322805-E72B8453-EDA5-4B9D-B779-6F0FDD5338C4Q36770595-18209FF7-5380-4AE0-8E23-49D87A3AA6E1Q37471129-6018F654-611A-47CC-8ED9-5A24836C3845Q37505009-E509B8B6-D0AA-4E75-A0C3-F41D709028CAQ37603244-D5AC4045-C39A-4BF8-8661-97F5423CE20DQ37728038-C51EB649-69BA-4626-A6FA-21D5A366F9DCQ38112165-89125E9B-17EF-43A8-BE63-C0584A030DC9Q38609767-861EE364-8AAD-4DF0-9525-CBD2B6366BF1Q38665575-F4EB1A6D-FD5A-4654-8817-BFCA4236A87EQ39442545-6C303642-1801-49D1-B921-C4161A11BFA5Q41726958-3BDA55AE-F736-4BB7-AF15-6C931B5F0AB5Q41935783-39125F8A-10E1-4FD8-8581-CE89708109E2Q42583421-2F848153-A120-4BD0-A9FD-C57ADB9C24BFQ45207632-B0569FB6-350B-42EE-8EAC-E1D367DD6651Q49028149-76AA7ABA-1EA3-49C3-935F-A97B2E722D8DQ52723411-14694A6F-35E1-4711-949A-D8E14352B09DQ53615353-A60BDAFD-A434-462C-8FA7-E75A944653E8Q54646301-722464A4-4B34-4E57-AA1B-3E75A90AFA93
P2860
Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy
@ast
Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy
@en
type
label
Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy
@ast
Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy
@en
prefLabel
Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy
@ast
Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy
@en
P2093
P2860
P356
P1476
Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy
@en
P2093
Chikage Sato-Horiguchi
Daisuke Ogawa
Dennis Bruemmer
Haruhito Adam Uchida
Hirofumi Makino
Hiromi Tachibana
Jun Eguchi
Kenichi Shikata
Sanae Teshigawara
Yuichi Matsushita
P2860
P304
P356
10.1681/ASN.2012010022
P50
P577
2012-10-18T00:00:00Z